Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with KATP channels

Acta Pharmacol Sin. 2019 Apr;40(4):569-570. doi: 10.1038/s41401-018-0088-5. Epub 2018 Sep 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenosine Triphosphate
  • Brain Ischemia*
  • Diabetes Mellitus*
  • Humans
  • Stroke*
  • Sulfonylurea Compounds

Substances

  • Sulfonylurea Compounds
  • Adenosine Triphosphate